ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105509 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105509; 2) Community: the network communities that were significantly associated with the response to NSC 105509; 3) Molecule: the relationships between components within communities and NSC 105509; 4) MDR: the compounds that were significantly associated with the NSC 105509.

NSC Compound Enrichment Correlation
NSC 112152 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) 0.0244632509325736 -0.20010832
NSC 145168 1H-Pyrrole-2,5-dione, 1-(1-hydroxy-2-oxopropyl)- 0.0244632509325736 -0.12335754
NSC 31709 Quinolinium, 2-[2-(2,5-dimethyl-1-pentyl-1H-pyrrol-3-yl)ethenyl]-1,6-dimethyl-, chloride 0.0244632509325736 -0.10977051
NSC 363812 Tetraplatin 0.0244632509325736 -0.34165552
NSC 380721 Eremantholide B 0.0244632509325736 -0.18703304
NSC 633203 Null 0.0244632509325736 0.45473974
NSC 645351 [Bis(aminomethyl)diethylsilane]dichloroplatinum (II) 0.0244632509325736 -0.33867517
NSC 652924 Null 0.0244632509325736 0.20479329
NSC 665700 Null 0.0244632509325736 -0.08220433
NSC 676395 Cyclobutanemethanol, 1-[[(2-amino-4-chloro-5-[(4-chlorophenyl)azo]- 6-pyrimidinyl)amino]methyl]-3-(3-phenylmethoxy)- 0.0244632509325736 0.18513401
Total:57  Current:30    [First] [Prev] [Next] [Last]